Binding studies on peptide-oligonucleotide complex: Intercalation of tryptophan in GC-rich region of c-myc gene

Biochimica et Biophysica Acta - General Subjects

Volumn 1622, Issue 2, 2003, Pages 73-81

  Jain, Akanchha Aklank ^a   Rajeswari, Moganty R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Binding studies; c myc; Oligonucleotide; Peptide; Tryptophan intercalation

Indexed keywords

NUCLEOTIDE; OLIGONUCLEOTIDE; OLIGOPEPTIDE; PEPTIDE; TETRAPEPTIDE; TRYPTOPHAN;

ABSORPTION SPECTROSCOPY; ARTICLE; CHEMICAL INTERACTION; CIRCULAR DICHROISM; ELECTRICITY; FLUORESCENCE SPECTROSCOPY; GENE EXPRESSION; GENE LOCATION; INTERCALATION COMPLEX; MELTING POINT; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN NUCLEIC ACID INTERACTION; TATA BOX; TEMPERATURE DEPENDENCE; ULTRAVIOLET SPECTROSCOPY;

EID: 0037767737     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(03)00119-3     Document Type: Article

References (36)

1. Cory S. Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv. Cancer Res. 47:1986;189-234.
2. Dang C.V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19(1):1999;1-11.
3. Cole M.D. The myc oncogene: its role in transformation and differentiation. Annu. Rev. Genet. 20:1986;361-384.
4. Nesbit C.E., Tersak J.M., Prochownik E.V. MYC oncogenes and human neoplastic disease. Oncogene. 18(19):1999;3004-3016.
5. Favera R.D., Staal F.W., Gallo R.C. Oncogene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature. 299(5878):1982 (Sep 2);61-63.
6. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 55:1990;133-270.
7. Payne G.S., Bishop J.M., Varmus H.E. Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature. 295(5846):1982 (Jan 21);209-214.
8. Battey J., Moulding C., Taub R., Murphy W., Stewart T., Poter H., Lenoir G., Leder P. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell. 34:1983;779-787.
9. Kim H.G., Reddoch J.F., Mayfield C., Ebbinghaus S., Vigneswaran N., Thomas S., Jones D.A., Miller D.M. Inhibition of transcription of the human c-myc proto-oncogene by intermolecular triplex. Biochemistry. 37:1998;2299-2304.
10. Watt R., Nishikura K., Sorrentino J., Ar-Rushdi A., Croce C.K., Rovera G. The structure and nucleotide sequence of the 5′ end to the human c-myc oncogene. Proc. Natl. Acad. Sci. U. S. A. 80:1983;6307-6311.
11. C.T. Denny, G.F. Hollis, I.T., Margrath, I.R. Kirsh, Burkitt lymphoma cell line carrying a variant translocation creates new DNA at the breakpoint and violates the hierarchy of immunoglobulin gene rearrangement, Mol. Cell. Biol. 5 (1985) 3199-3207.
12. Catapano C.V., McGuffie E.M., Pacheco D., Carbone G.M.R. Inhibition of gene expression and cell proliferation by triple helix-forming oligonucleotides directed to the c-myc gene. Biochemistry. 39:2000;5126-5138.
13. Sastry M., Patel D.J. Solution structure of the mithramycin dimer-DNA complex. Biochemistry. 32(26):1993;6588-6604.
14. Vaquero M., Portugal J. Modulation of DNA-protein interaction in the P1 and P2 c-myc promoter by two intercalating drugs. Eur. J. Biochem. 251:1998;435-442.
15. Vigneswaran N., Mayfield C.A., Rodu B., James R., Kim H.G., Miller D.M. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter. Biochemistry. 35(4):1996;1106-1114.
16. Allen S.L., Schacter L.P., Lichtman S.M., Bukowski R., Fusco D., Hensley M., O'Dwyer P., Mittlelman A., Rosenbloom B., Huybensz S. Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma. Invest. New Drugs. 14:1996;213-217.
17. Hassan H.T., Rees J.K. Low concentrations of cytosine arabinoside, 6-thioguanine, actinomycin-D and aclacinomycin A stimulates the differentiation of normal human marrow myeloid progenitor cells. Med. Oncol. Tumor Pharmacother. 6:1989;213-217.
18. Briggs M.R., Kandonaga J.T., Bell S.P., Tijan R. Purification and biochemical characterization of the promoter specific transcription factor Sp1. Science. 234:1986;47-52.
19. Chaudhary D., Miller D.M. The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously ion the minor groove of c-myc P2 promoter. Biochemistry. 34:1995;3438-3445.
20. Berk A.J. TBP-like factors come into focus. Cell. 103:2000;5-8.
21. Rajeswari M.R., Montenay-Garestier T., Helene C. Does tryptophan intercalate in DNA? A comparative study of peptide binding to alternating and nonalternating A·T sequences. Biochemistry. 26:1987;6825-6831.
22. Rajeswari M.R. Tryptophan intercalation in G,C containing polynucleotides: Z to B conversion of poly [d(G-5MC)] in low salt induced by A tetra peptide. J. Biomol. Struct. Dyn. 14:1996;25-30.
23. Roy K.B., Kukreti S., Bose H.S., Chauhan V.S., Rajeswari M.R. Hairpin and duplex forms of a self-complementary dodecamer, d-AGATCTAGATCT, and interaction of the duplex form with the peptide KGWGK: can a pentapeptide destabilize DNA? Biochemistry. 131:1992;6241-6245.
24. Rajeswari M.R., Bose H.S., Kukerti S., Gupta A., Chauhan V.S., Roy K.B. Binding of oligopeptides d-AGATCTAGATCT and d-AAGCTTAAGCTT: can tryptophan intercalate in DNA hairpins? Biochemistry. 31:1992;6237-6241.
25. Cantor C.R., Warshaw M.M., Shapiro H. Oligonucleotide interactions: circular dichroism studies of the conformation of deoxyoligonucleotides. Biopolymers. 9(9):1970;1059-1077.
26. Marky L.A., Breslauer K.J. Calculating thermodynamic data for transitions of any molecularity from equilibrium melting curves. Biopolymers. 26(9):1987;1601-1620.
27. Chiang S.Y., Welch J.J., Rauscher F.J., Beerman T.A. Effect of DNA binding drugs on early growth response factor and TATA box-binding protein complex formation with the herpes simplex virus latency promoter. J. Biol. Chem. 271:1996;23990-24004.
28. Welch J.J., Rausher F.J., Beerman T.A. Targeting DNA-binding drugs to sequence specific transcription factor DNA complexes differential effects of intercalating and minor groove binding drugs. J. Biol. Chem. 269:1994;31051-31058.
29. Bianchi N., Passadore M., Rutigliano C., Feriotto G., Mischiat C., Gambari R. Targeting of the Sp1 binding sites at HIV-1 long terminal repeat with chloromomycin-disruption of nuclear factor DNA complexes and inhibition of in vitro transcription. Biochem. Pharmacol. 52:1996;1489-1498.
30. Bellorini M., Moncollin V., Dinacalci M., Mongelli N., Manvani R. Distamycin and tallimustine inhibit TBP binding and basal in vitro transcription. Nucleic Acids Res. 23:1995;1657-1663.
31. Brun F., Toulme J.J., Helene C. Interactions of aromatic residues of proteins with nucleic acids. Fluorescence studies of the binding of oligopeptides containing tryptophan and tyrosine residues to polynucleotides. Biochemistry. 14:1975;558-562.
32. Helene C., Maurizot J.C. Interactions of oligopeptides with nucleic acids. CRC Crit. Rev. Biochem. 10:1981;213-258.
33. Toulme J.J., Helene C. Specific recognition of single-stranded nucleic acids interaction of tryptophan-containing peptides with native, denatured and ultraviolet-irradiated DNA. J. Biol. Chem. 252:1977;244-249.
34. Helene C., Lancelot G. Interactions between functional groups in protein-nucleic acid associations. Prog. Biophys. Mol. Biol. 39(1):1982;1-68.
35. Roy K.B., Kukreti S., Chauhan V.S., Rajeswari M.R. Hairpin formation in d-AAGCTTAAGCTT under high salt conditions shows unusual properties. J. Biomol. Struct. Dyn. 11:1994;1041-1048.
36. Auer H.E. Far-ultraviolet absorption and circular dichroism spectra of L-tryptophan and some derivatives. J. Am. Chem. Soc. 95(9):1973;3003-3011.